Canrenoate potassium
产品说明书
 |
同义名 : | 刊利酸钾 ;Aldadiene potassium;SC-14266 |
| CAS号 : | 2181-04-6 | |
| 货号 : | A501269 | |
| 分子式 : | C22H29KO4 | |
| 纯度 : | 98% | |
| 分子量 : | 396.562 | |
| MDL号 : | MFCD05662375 | |
| 存储条件： |
Pure form 2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : |
H2O: 100 mg/mL(252.17 mM)，配合低频超声，并水浴加热至45℃助溶 |
|
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | Potassium canrenoate, the potassium salt of canrenoic acid, is an aldosterone antagonist of the spirolactone group. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT01059136 | Myocardial Infarction | Phase 3 | Completed | - | France ... 展开 >> Hôpital PITIE-SALPETRIERE - Institut de Cardiologie Paris, France, 75013 收起 << |
| NCT01882179 | ST-elevation Myocardial Infarc... 展开 >>tion 收起 << | Phase 3 | Completed | - | United Kingdom ... 展开 >> Cardiothoracic Center - Basildon and Thurrock University Hospitals Basildon, Essex, United Kingdom, SS16 5NL Leeds Genereal Infirmary Leeds, United Kingdom London Chest Hospital London, United Kingdom, E2 9JX Heart Hospital London London, United Kingdom, W1G 8PH 收起 << |
| NCT00741663 | Cirrhosis Asc... 展开 >>ites 收起 << | Phase 4 | Completed | - | Italy ... 展开 >> University of Padova, Dept. of Clinical and Experimental Medicine Padova, Italy, 35100 收起 << |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.52mL 0.50mL 0.25mL |
12.61mL 2.52mL 1.26mL |
25.22mL 5.04mL 2.52mL |
| 参考文献 |
|---|